WednesdayJul 28, 2021 12:09 pm

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Eyes Clear Opportunity to Bring Impactful Therapy to GBM Patients

CNS Pharmaceuticals (NASDAQ: CNSP) is a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system. Over recent months, the company has achieved several milestones demonstrating its operational, financial and strategic strengths and continuous de-risking of its lead candidate Berubicin clinical program. “The company has begun a pivotal Phase 2 clinical trial evaluating the efficacy and safety of Berubicin for recurrent adult glioblastoma multiforme (‘GBM’). Enrollment in the clinical trial is already underway, with patient dosing set to begin in Q3 2021,” reports an article discussing the status of…

Continue Reading

WednesdayJul 28, 2021 11:58 am

QualityStocksNewsBreaks – Nextech AR Solutions Corp. (OTCQB: NEXCF) (NEO: NTAR) (CSE: NTAR) (FSE: N29) to Release Q2 2021 Earnings, Schedules Earnings Call

Nextech AR Solutions (OTCQB: NEXCF) (NEO: NTAR) (CSE: NTAR) (FSE: N29), a diversified leading provider of augmented reality (“AR”) solutions and services, has announced plans to release its second-quarter 2021 financial results on Aug. 11, 2021, after markets close. The company will also host a conference call to discuss its financial numbers and results on Aug. 12 , 2021, at 1 p.m. ET. Nextech CEO Evan Gappelberg and CFO Andrew Chan will host the call and provide an overview of company financial and operating results; the call will also include a question-and-answer period. Interested individuals can call in toll-free by dialing…

Continue Reading

WednesdayJul 28, 2021 11:09 am

QualityStocksNewsBreaks – Excellon Resources Inc. (TSX: EXN) (NYSE American: EXN) (FSE: E4X2) Announces Progress of Silver City Drilling Program

Excellon Resources (TSX: EXN) (NYSE American: EXN) (FSE: E4X2) today provided an update on the ongoing drilling program at the Silver City Project located in Saxony, Germany. Among the highlights, the company reported smooth commencement of drilling at the first of four priority targets of the 12,000-metre diamond drilling program planned for 2021. In addition, a second drill rig was added to the program, with drilling now underway at the Peter Vein (Neue Hoffnung Gottes) and Bräunsdorf (Christbescherung) targets. “We have had another smooth startup of drilling at Silver City this year,” said Ben Pullinger, SVP Geology & Corporate Development.…

Continue Reading

WednesdayJul 28, 2021 10:51 am

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Reaches Milestone in Human Clinical Study, Notes Growing Availability of DehydraTECH-Enabled Products

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, has reached a significant point in its second human clinical study of 2021: HYPER-H21-2. The company announced that dosing has been completed in the study, which was comprised of 16 human volunteers who were pre- or mildly hypertensive; each participant received three separate doses of 150 mg each of DehydraTECH(TM) 2.0-enabled CBD versus a placebo. The study also included 24-hour continuous monitoring of blood pressure and heart rate, as well as evaluations of central arterial stiffness, physical activity and sleep quality. This key information will be assessed to evaluate the…

Continue Reading

WednesdayJul 28, 2021 10:43 am

QualityStocksNewsBreaks – XPhyto Therapeutics Corp.’s (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Acquisition Target Identifies Breakthrough COVID-19 Detection Biosensor Candidates

XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT), a life sciences technology accelerator, today announced that its acquisition target, 3a-diagnostics GmbH (“3a”), has identified the first saliva activated “in-mouth” biosensor candidates for the detection of a COVID-19 infection. According to the update, the enzyme-activated biosensors are developed for real-time, low-cost and easy-to-use oral screening applications for the rapid detection of infectious diseases including COVID-19 at home or at the point-of-care. “We believed in 3a’s research and development plan from the beginning, when we signed the first collaboration contract in 2020. Now that XPhyto has announced the pending acquisition of 3a,…

Continue Reading

WednesdayJul 28, 2021 10:14 am

QualityStocksNewsBreaks – Petroteq Energy Inc. (TSX.V: PQE) (OTC: PQEFF) (FSE: PQCF) Announces Completion of FEED Study for Plant Employing CORT Process

Petroteq Energy (TSX.V: PQE) (OTC: PQEFF) (FSE: PQCF), an integrated oil company focused on the development and implementation of its proprietary oil-extraction and remediation technologies, today announced that the Front End Engineering and Design (“FEED”) Study for a proposed 5,000 barrels of oil per day (“bopd”) production facility employing Petroteq’s Clean Oil Recovery Technology (“CORT”) process has been completed by Crosstrails Engineering LLC. The study is expected to be delivered to Petroteq later this week. This FEED encompasses a production train capable of processing 5,000 bopd from mined oil sands ore. Petroteq anticipates that this FEED can become the starting…

Continue Reading

WednesdayJul 28, 2021 10:01 am

QualityStocksNewsBreaks – Net Element Inc. (NASDAQ: NETE) Updates Shareholders, Announces Registration Statement for Proposed Merger Declared Effective by SEC

Net Element (NASDAQ: NETE), a financial technology company in the process of becoming a pure-play electric vehicle (“EV”) manufacturer through a pending definitive agreement with privately held Mullen Automotive Inc., has shared key updates with shareholders. Earlier this year, the company purchased more than 100 acres along with a 120,000-square-foot facility, which will become the company’s Advanced Engineering and Manufacturing Center and Proving Grounds (“AMEC”); the property is located in Tunica, Mississippi. The company intends to construct a 700,000-square-foot body shop, paint shop, warehouse and test track to complete an automotive campus with more than 820,000 square feet of building space and the…

Continue Reading

WednesdayJul 28, 2021 9:43 am

QualityStocksNewsBreaks – Kaival Brands Innovations Group Inc. (KAVLD) Announces Approval to Trade on Nasdaq Exchange

Kaival Brands (OTCQB: KAVLD), the exclusive global distributor of products manufactured by Bidi(R) Vapor LLC, has received approval from the Nasdaq Stock Market LLC to list the company’s common stock on the Nasdaq Market; the listing will be effective beginning Thursday, July 29, 2021. The announcement noted that the company’s ticker symbol, KAVL, will remain unchanged. The announcement noted that Bidi Vapor’s founding mission is to provide recreational, noncombusted alternatives for adult cigarette smokers including the BIDI(R) Stick and the BIDI(R) Pouch. “I am pleased to announce that the company has been approved to begin trading on Nasdaq,” said Kaival…

Continue Reading

TuesdayJul 27, 2021 3:43 pm

QualityStocksNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Eyes Expanded Customer Base, Multiple Collaborations, Fulfillment of Researchers’ Needs

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, recently announced that two of its four subsidiaries, Soluble Biotech and TumorGenesis, are expanding their services with the construction of new good manufacturing practices (“GMP”) laboratories. For Soluble Biotech, the GMP facility ramps up its formulation solutions and stability services so the company can rapidly provide clinical-trial-ready formulations to its customers. The lab will also be utilized to produce proprietary media used in its chromatography kits. A recent article reads, “Dr. Larry DeLucas, VP of Operations at Predictive Oncology, said he…

Continue Reading

TuesdayJul 27, 2021 3:32 pm

QualityStocksNewsBreaks – MedSmart Group Inc. (MSGP) Announces New Vision and Direction, Planned Acquisition of Autonomous and Robotic Systems Leader Milanion

MedSmart Group (OTC: MSGP) today officially announced the appointment of its new president, Davinder Dogra, along with a new strategic vison and direction leading to the acquisition of Milanion Limited, the leading developer of disruptive autonomous and robotic solutions. According to the update, Milanion is an integrated defense and security technology company that designs and manufactures advanced defense equipment and systems in the autonomous and robotics sector. Milanion utilizes the latest artificial intelligence (“AI”) technologies, developed to support a range of unmanned autonomous and electric vehicle (“EV”) platforms, to create the most effective, efficient battle-ready systems for land, marine and…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered